Search

Home > GRACEcast Lung Cancer Video > ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC (video)
Category: Science & Medicine
Duration: 00:05:45
Publish Date: 2013-08-26 23:55:19
Description:

Dr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.
Total Play: 0